维拉帕米可预防急性心肌梗死后心脏增大患者的猝死。 - Suppr

Suppr

超能文献

Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction.

作者信息

Hansen J F

出版信息

Cardiovasc Drugs Ther. 1993 Jun;7(3):381-2. doi: 10.1007/BF00880163.

DOI:10.1007/BF00880163

PMID:8364008

Abstract

摘要

相似文献

Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction.维拉帕米可预防急性心肌梗死后心脏增大患者的猝死。

Cardiovasc Drugs Ther. 1993 Jun;7(3):381-2. doi: 10.1007/BF00880163.

Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction.急性心肌梗死期间及之后使用维拉帕米治疗：基于丹麦维拉帕米梗死试验I和II的综述。丹麦心肌梗死维拉帕米研究小组。

J Cardiovasc Pharmacol. 1991;18 Suppl 6:S20-5.

Verapamil and circadian variation of sudden cardiac death.

Am Heart J. 1996 Feb;131(2):409-10. doi: 10.1016/s0002-8703(96)90378-6.

How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?血管紧张素转换酶抑制剂如何降低伴有或不伴有心力衰竭的左心室功能不全患者的死亡率：重塑、重置还是猝死？

Br Heart J. 1994 Sep;72(3 Suppl):S81-6. doi: 10.1136/hrt.72.3_suppl.s81.

Less heart is more.少些用心，反而更好。

Circulation. 2003 May 27;107(20):2531-2. doi: 10.1161/01.CIR.0000068687.46373.04.

[Calcium antagonists. The prevention of a recurrent myocardial infarct and sudden death].[钙拮抗剂。复发性心肌梗死和猝死的预防]

Ter Arkh. 1992;64(9):50-3.

Verapamil in acute myocardial infarction.

Clin Invest Med. 1980;3(1-2):159-63.

[Prevention of sudden death and the countermeasures--cardiac sudden death and acute myocardial infarction--ideal emergicenters].[猝死的预防及对策——心源性猝死与急性心肌梗死——理想的急救中心]

Nihon Naika Gakkai Zasshi. 1998 Jan 10;87(1):98-104.

Verapamil and sudden death.维拉帕米与猝死

Am J Cardiol. 1978 Sep;42(3):524-5. doi: 10.1016/0002-9149(78)90957-8.

Verapamil in acute myocardial infarction.

Dan Med Bull. 1980 Apr;27(2):105-9.

引用本文的文献

Calcium channel antagonists should be among the first-line drugs in the management of cardiovascular disease.

Cardiovasc Drugs Ther. 1996 Sep;10(4):455-61. doi: 10.1007/BF00051110.

ACE inhibitors and calcium antagonists in the treatment of congestive heart failure.血管紧张素转换酶抑制剂和钙拮抗剂在充血性心力衰竭治疗中的应用

Cardiovasc Drugs Ther. 1995 Aug;9 Suppl 3:503-7. doi: 10.1007/BF00877862.

本文引用的文献

The effect of diltiazem on mortality and reinfarction after myocardial infarction.

N Engl J Med. 1988 Aug 18;319(7):385-92. doi: 10.1056/NEJM198808183190701.

Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.

Eur Heart J. 1988 Apr;9(4):354-64.

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II).

Am J Cardiol. 1990 Oct 1;66(10):779-85. doi: 10.1016/0002-9149(90)90351-z.

Calcium antagonists and cardiac noradrenaline release in ischemia.钙拮抗剂与缺血时心脏去甲肾上腺素的释放

J Mol Cell Cardiol. 1991 Mar;23(3):269-77. doi: 10.1016/0022-2828(91)90063-r.

Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity.心肌梗死后是否应使用钙拮抗剂？缺血选择性与血管选择性。

Cardiovasc Drugs Ther. 1992 Feb;6(1):19-24. doi: 10.1007/BF00050912.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验